Keyphrases
Glial Tumors
100%
Multiplex Ligation-dependent Probe Amplification
100%
Diagnostic Tool
100%
Genetic Markers
100%
Simultaneous Identification
100%
Tumor
50%
Genetic Aberrations
33%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
16%
Routine Diagnostics
16%
Polymerase Chain Reaction
16%
Loss of Heterozygosity
16%
Clinical Behavior
16%
Glioma
16%
Tumor DNA
16%
Gene Copy number Variation
16%
Fluorescence in Situ Hybridization
16%
Chemosensitivity
16%
High-grade Malignancy
16%
Reaction-based
16%
Comparative Genomic Hybridization
16%
1p36
16%
Partial Loss
16%
Prediction Accuracy
16%
1p Deletion
16%
Multiple Changes
16%
Diagnostic Strategy
16%
DNA Detection
16%
P105
16%
Simultaneous Detection
16%
Biochemistry, Genetics and Molecular Biology
Multiplex Ligation-Dependent Probe Amplification
100%
Genetic Marker
100%
Genetics
33%
Epidermal Growth Factor Receptor
16%
Comparative Genomic Hybridization
16%
Loss of Heterozygosity
16%
Gene Dosage
16%
Fluorescence in Situ Hybridization
16%
Chemosensitivity
16%
Polymerase Chain Reaction
16%
Neuroscience
Multiplex Ligation-Dependent Probe Amplification
100%
Genetic Marker
100%
Behavior (Neuroscience)
16%
In Situ Hybridization
16%
Comparative Genomics
16%
Gene Dosage
16%
Epidermal Growth Factor Receptor
16%
Polymerase Chain Reaction
16%